Clinical Trial Update: Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating fondaparinux sodium for venous thromboembolism prevention in Japanese patients undergoing abdominal surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED